321 related articles for article (PubMed ID: 21802200)
1. Ovarian clear cell carcinoma as a stress-responsive cancer: influence of the microenvironment on the carcinogenesis and cancer phenotype.
Mandai M; Matsumura N; Baba T; Yamaguchi K; Hamanishi J; Konishi I
Cancer Lett; 2011 Nov; 310(2):129-33. PubMed ID: 21802200
[TBL] [Abstract][Full Text] [Related]
2. Comparative immunohistochemical studies of bcl-2 and p53 proteins in benign and malignant ovarian endometriotic cysts.
Nezhat F; Cohen C; Rahaman J; Gretz H; Cole P; Kalir T
Cancer; 2002 Jun; 94(11):2935-40. PubMed ID: 12115382
[TBL] [Abstract][Full Text] [Related]
3. A series of ovarian clear cell and endometrioid carcinoma and their association with endometriosis.
Chew S; Tham KF; Ratnam SS
Singapore Med J; 1997 Jul; 38(7):289-91. PubMed ID: 9339094
[TBL] [Abstract][Full Text] [Related]
4. Ovarian cancer in endometriosis: molecular biology, pathology, and clinical management.
Mandai M; Yamaguchi K; Matsumura N; Baba T; Konishi I
Int J Clin Oncol; 2009 Oct; 14(5):383-91. PubMed ID: 19856044
[TBL] [Abstract][Full Text] [Related]
5. Endometrioid adenocarcinoma of the ovary and endometriosis.
Valenzuela P; Ramos P; Redondo S; Cabrera Y; Alvarez I; Ruiz A
Eur J Obstet Gynecol Reprod Biol; 2007 Sep; 134(1):83-6. PubMed ID: 16844279
[TBL] [Abstract][Full Text] [Related]
6. Genomic imbalance and onco-protein expression of ovarian endometrioid adenocarcinoma arisen in an endometriotic cyst.
Noack F; Schmidt H; Buchweitz O; Malik E; Horny HP
Anticancer Res; 2004; 24(1):151-4. PubMed ID: 15015590
[TBL] [Abstract][Full Text] [Related]
7. [Prevalence of endometriosis in ovarian cancer].
Iwase H; Yoshikawa H
Nihon Rinsho; 2001 Jan; 59 Suppl 1():208-12. PubMed ID: 11235167
[No Abstract] [Full Text] [Related]
8. Perimenopausal management of ovarian endometriosis and associated cancer risk: When is medical or surgical treatment indicated?
Vercellini P; Viganò P; Buggio L; Makieva S; Scarfone G; Cribiù FM; Parazzini F; Somigliana E
Best Pract Res Clin Obstet Gynaecol; 2018 Aug; 51():151-168. PubMed ID: 29551389
[TBL] [Abstract][Full Text] [Related]
9. Endometriosis and the development of malignant tumours of the pelvis. A review of literature.
Van Gorp T; Amant F; Neven P; Vergote I; Moerman P
Best Pract Res Clin Obstet Gynaecol; 2004 Apr; 18(2):349-71. PubMed ID: 15157647
[TBL] [Abstract][Full Text] [Related]
10. Morphological subtypes of ovarian carcinoma: a review with emphasis on new developments and pathogenesis.
McCluggage WG
Pathology; 2011 Aug; 43(5):420-32. PubMed ID: 21716157
[TBL] [Abstract][Full Text] [Related]
11. Clinicopathological characteristics of ovarian carcinomas associated with endometriosis.
Kondi-Pafiti A; Papakonstantinou E; Iavazzo C; Grigoriadis C; Salakos N; Gregoriou O
Arch Gynecol Obstet; 2012 Feb; 285(2):479-83. PubMed ID: 21717140
[TBL] [Abstract][Full Text] [Related]
12. Differences in LINE-1 methylation between endometriotic ovarian cyst and endometriosis-associated ovarian cancer.
Senthong A; Kitkumthorn N; Rattanatanyong P; Khemapech N; Triratanachart S; Mutirangura A
Int J Gynecol Cancer; 2014 Jan; 24(1):36-42. PubMed ID: 24304685
[TBL] [Abstract][Full Text] [Related]
13. Immunohistochemistry expression of targeted therapies biomarkers in ovarian clear cell and endometrioid carcinomas (type I) and endometriosis.
Barreta A; Sarian LO; Ferracini AC; Costa LBE; Mazzola PG; de Angelo Andrade L; Derchain S
Hum Pathol; 2019 Mar; 85():72-81. PubMed ID: 30447298
[TBL] [Abstract][Full Text] [Related]
14. CDC42-positive macrophages may prevent malignant transformation of ovarian endometriosis.
Canet B; Pons C; Espinosa I; Prat J
Hum Pathol; 2012 May; 43(5):720-5. PubMed ID: 21944080
[TBL] [Abstract][Full Text] [Related]
15. Loss of ARID1A expression is an early molecular event in tumor progression from ovarian endometriotic cyst to clear cell and endometrioid carcinoma.
Ayhan A; Mao TL; Seckin T; Wu CH; Guan B; Ogawa H; Futagami M; Mizukami H; Yokoyama Y; Kurman RJ; Shih IeM
Int J Gynecol Cancer; 2012 Oct; 22(8):1310-5. PubMed ID: 22976498
[TBL] [Abstract][Full Text] [Related]
16. Molecular pathogenesis of endometriosis-associated clear cell carcinoma of the ovary (review).
Kobayashi H; Kajiwara H; Kanayama S; Yamada Y; Furukawa N; Noguchi T; Haruta S; Yoshida S; Sakata M; Sado T; Oi H
Oncol Rep; 2009 Aug; 22(2):233-40. PubMed ID: 19578761
[TBL] [Abstract][Full Text] [Related]
17. [Clinical discussion of the relationship between endometriosis and epithelial ovarian cancer].
Zhang Y; Huang H; Lian L
Zhonghua Fu Chan Ke Za Zhi; 1999 Sep; 34(9):544-6. PubMed ID: 11360640
[TBL] [Abstract][Full Text] [Related]
18. Histological classification of ovarian cancer.
Kaku T; Ogawa S; Kawano Y; Ohishi Y; Kobayashi H; Hirakawa T; Nakano H
Med Electron Microsc; 2003 Mar; 36(1):9-17. PubMed ID: 12658347
[TBL] [Abstract][Full Text] [Related]
19. Molecular mechanisms linking endometriosis under oxidative stress with ovarian tumorigenesis and therapeutic modalities.
Shigetomi H; Tsunemi T; Haruta S; Kajihara H; Yoshizawa Y; Tanase Y; Furukawa N; Yoshida S; Sado T; Kobayashi H
Cancer Invest; 2012 Jul; 30(6):473-80. PubMed ID: 22530740
[TBL] [Abstract][Full Text] [Related]
20. Identification of an ovarian clear cell carcinoma gene signature that reflects inherent disease biology and the carcinogenic processes.
Yamaguchi K; Mandai M; Oura T; Matsumura N; Hamanishi J; Baba T; Matsui S; Murphy SK; Konishi I
Oncogene; 2010 Mar; 29(12):1741-52. PubMed ID: 20062075
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
